Date: 2017-03-23
Type of information: Distribution agreement
Compound: UrNCollect™
Company: Novosanis (Belgium) MDxHealth (Belgium)
Therapeutic area: Technology - Services - Diagnostic
Type agreement: distribution
Action mechanism: medical device. UrNCollect™ is a customized version of Novosanis’ patented urine collection device called Colli-Pee™. Colli-Pee™ is a device used to efficiently capture first-void urine (first part of the urine flow). Collection of first-void urine allows for detection of sexually transmitted infections, including Chlamydia, gonorrhea and Human Papilloma Virus, as well as cancer biomarkers. The Colli-Pee device platform allows for collection of different pre-defined volumes for a range of medical applications.
Disease:
Details: * On March 23, 2017, Novosanis and MDxHealth have signed an agreement to supply UrNCollect™, a customized version of Novosanis’ patented urine collection device called Colli-Pee™. The medical device facilitates accurate sample collection for urine-based tests. It allows for a standardized, hygienic and user-friendly collection of the first 20ml of the urine stream and reduces lab errors by automating preservative mixing without additional handling.
Financial terms:
Latest news:
